We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Congressmen Criticize FDA Heparin Investigation
Congressmen Criticize FDA Heparin Investigation
May 3, 2010
The FDA has failed to adequately follow up on specific and credible information linking Chinese heparin sources to counterfeit or contaminated heparin
in several different supply chains, according to members of Congress.